These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 37495303)

  • 1. Prevalence, molecular and phenotypic profiles of arboreal associated Cryptococcus neoformans in Botswana.
    Tshekiso K; Loeto D; Muzila M; Seetswane E; Kenosi K; Jongman M
    Fungal Biol; 2023; 127(7-8):1129-1135. PubMed ID: 37495303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular typing and in vitro resistance of Cryptococcus neoformans clinical isolates obtained in Germany between 2011 and 2017.
    Selb R; Fuchs V; Graf B; Hamprecht A; Hogardt M; Sedlacek L; Schwarz R; Idelevich EA; Becker SL; Held J; Küpper-Tetzel CP; McCormick-Smith I; Heckmann D; Gerkrath J; Han CO; Wilmes D; Rickerts V
    Int J Med Microbiol; 2019 Sep; 309(6):151336. PubMed ID: 31444102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel hybrids between Cryptococcus neoformans var. grubii VNI and Cryptococcus gattii VGII.
    Aminnejad M; Diaz M; Arabatzis M; Castañeda E; Lazera M; Velegraki A; Marriott D; Sorrell TC; Meyer W
    Mycopathologia; 2012 Jun; 173(5-6):337-46. PubMed ID: 22081254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Prevalence of HIV-Related Cryptococcosis and Increased Resistance to Fluconazole of the
    Yang C; Bian Z; Blechert O; Deng F; Chen H; Li Y; Yang Y; Chen M; Zhan P
    Front Cell Infect Microbiol; 2021; 11():723251. PubMed ID: 34790585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular epidemiology and in vitro antifungal susceptibility testing of 108 clinical Cryptococcus neoformans sensu lato and Cryptococcus gattii sensu lato isolates from Denmark.
    Hagen F; Hare Jensen R; Meis JF; Arendrup MC
    Mycoses; 2016 Sep; 59(9):576-84. PubMed ID: 27061834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analyses of clinical and environmental populations of Cryptococcus neoformans in Botswana.
    Chen Y; Litvintseva AP; Frazzitta AE; Haverkamp MR; Wang L; Fang C; Muthoga C; Mitchell TG; Perfect JR
    Mol Ecol; 2015 Jul; 24(14):3559-71. PubMed ID: 26053414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-locus sequence typing reveals genotypic similarity in Nigerian
    Chidebelu PE; Nweze EI; Meis JF; Cogliati M; Hagen F
    J Med Microbiol; 2021 Oct; 70(10):. PubMed ID: 34665109
    [No Abstract]   [Full Text] [Related]  

  • 8. Multilocus sequence typing reveals three genetic subpopulations of Cryptococcus neoformans var. grubii (serotype A), including a unique population in Botswana.
    Litvintseva AP; Thakur R; Vilgalys R; Mitchell TG
    Genetics; 2006 Apr; 172(4):2223-38. PubMed ID: 16322524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization and antifungal susceptibility testing of Cryptococcus neoformans sensu stricto from southern Brazil.
    Herkert PF; Meis JF; Lucca de Oliveira Salvador G; Rodrigues Gomes R; Aparecida Vicente V; Dominguez Muro M; Lameira Pinheiro R; Lopes Colombo A; Vargas Schwarzbold A; Sakuma de Oliveira C; Simão Ferreira M; Queiroz-Telles F; Hagen F
    J Med Microbiol; 2018 Apr; 67(4):560-569. PubMed ID: 29461182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antifungal susceptibility profiles and genotypes of 308 clinical and environmental isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii serotype B from north-western India.
    Chowdhary A; Randhawa HS; Sundar G; Kathuria S; Prakash A; Khan Z; Sun S; Xu J
    J Med Microbiol; 2011 Jul; 60(Pt 7):961-967. PubMed ID: 21393452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that the human pathogenic fungus Cryptococcus neoformans var. grubii may have evolved in Africa.
    Litvintseva AP; Carbone I; Rossouw J; Thakur R; Govender NP; Mitchell TG
    PLoS One; 2011 May; 6(5):e19688. PubMed ID: 21589919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analyses of pediatric isolates of Cryptococcus neoformans from South Africa.
    Miglia KJ; Govender NP; Rossouw J; Meiring S; Mitchell TG;
    J Clin Microbiol; 2011 Jan; 49(1):307-14. PubMed ID: 20980574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotypic diversity in clinical and environmental isolates of Cryptococcus neoformans from India using multilocus microsatellite and multilocus sequence typing.
    Prakash A; Sundar G; Sharma B; Hagen F; Meis JF; Chowdhary A
    Mycoses; 2020 Mar; 63(3):284-293. PubMed ID: 31820495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of sexual recombination among Cryptococcus neoformans serotype A isolates in sub-Saharan Africa.
    Litvintseva AP; Marra RE; Nielsen K; Heitman J; Vilgalys R; Mitchell TG
    Eukaryot Cell; 2003 Dec; 2(6):1162-8. PubMed ID: 14665451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular epidemiology and antifungal susceptibility of Serbian Cryptococcus neoformans isolates.
    Arsic Arsenijevic V; Pekmezovic MG; Meis JF; Hagen F
    Mycoses; 2014 Jun; 57(6):380-7. PubMed ID: 24438323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization and antifungal susceptibility of Cryptococcus neoformans strains collected from a single institution in Lima, Peru.
    Bejar V; Tello M; García R; Guevara JM; Gonzales S; Vergaray G; Valencia E; Abanto E; Ortega-Loayza AG; Hagen F; Gutierrez EL
    Rev Iberoam Micol; 2015; 32(2):88-92. PubMed ID: 25556051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiological characteristics of clinical isolates of Cryptococcus neoformans in Taiwan: serotypes, mating types, molecular types, virulence factors, and antifungal susceptibility.
    Liaw SJ; Wu HC; Hsueh PR
    Clin Microbiol Infect; 2010 Jun; 16(6):696-703. PubMed ID: 19694765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Many globally isolated AD hybrid strains of Cryptococcus neoformans originated in Africa.
    Litvintseva AP; Lin X; Templeton I; Heitman J; Mitchell TG
    PLoS Pathog; 2007 Aug; 3(8):e114. PubMed ID: 17708680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotypic diversity and antifungal susceptibility of environmental isolates of Cryptococcus neoformans from the Yangtze River Delta region of East China.
    Chen M; Wang Y; Li Y; Hong N; Zhu X; Pan W; Liao W; Xu J; Du J; Chen J
    Med Mycol; 2021 Jul; 59(7):653-663. PubMed ID: 33269400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotypic analysis of clinical and environmental Cryptococcus neoformans isolates from Brazil reveals the presence of VNB isolates and a correlation with biological factors.
    Andrade-Silva LE; Ferreira-Paim K; Ferreira TB; Vilas-Boas A; Mora DJ; Manzato VM; Fonseca FM; Buosi K; Andrade-Silva J; Prudente BDS; Araujo NE; Sales-Campos H; da Silva MV; Júnior VR; Meyer W; Silva-Vergara ML
    PLoS One; 2018; 13(3):e0193237. PubMed ID: 29505557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.